Secondary tricuspid regurgitation or dilatation: which should be the criteria for surgical repair?
By G. Dreyfus, P. Corbi, K. Chan, T. Bahrami. Annals of Thoracic Surgery, 2005
818 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Epidemiology, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/ca291f51c7806259c56b0737c3952ac931b1d74a
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
- Jeroen J. Bax
- Helmut Baumgartner
- Rick A. Nishimura
- Gerasimos Filippatos
- Volkmar Falk
- Jose Luis Zamorano
- P. Lancellotti
- A. Vahanian
In Epidemiology
- Jeroen J. Bax
- Helmut Baumgartner
- Rick A. Nishimura
- Jose Luis Zamorano
- P. Lancellotti
- A. Vahanian
- Stephan Windecker
Citations in the corpus
- [2017 ESC/EACTS Guidelines for the management of valvular heart disease]. (2017, background): “In secondary tricuspid regurgitation, adding a tricuspid repair, if indicated, during left-sided surgery does not increase operative risk and has been demonstrated to provide reverse remodelling of the RV and improvement of functional status even in the absence of substantial tricuspid regurgitation”
- 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014, background): “TTE is indicated for baseline evaluation of LV size and function, right ventricular (RV) function and left atrial size, pulmonary artery pressure, and mechanism and severity of primary MR (stages A to D) in any patient suspected of having chronic primary MR (6, 23, 146-162).”
- Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). (2012, neutral): “20–35% at 5 years.(179,180,185,186) Current experience favours the use of ring annuloplasty for severe TR related to isolated tricuspid annular dilatation.”
- Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. (2009, neutral): “40 mm seems to be more reliable than quantitation of regurgitation to predict the risk of severe late TR after mitral surgery.(2,67)”
- Guidelines on the management of valvular heart disease The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (2006, background): “Better long-term results are observed with prosthetic rings than with the suture annuloplasty, the incidence of residual TR being, respectively, 10% vs 20–35% at 5 years [179, 180, 185, 186].”